NEJM:发现与睾丸癌有关的自身免疫性疾病

2021-07-09 Viho MedSci原创

科学家们利用先进技术,发现了一种似乎会影响男性睾丸癌患者的自身免疫疾病。这种疾病被称为 "睾丸癌相关的副肿瘤性脑炎",会导致男性出现严重的神经系统症状。

科学家们利用先进技术,发现了一种似乎会影响男性睾丸癌患者的自身免疫疾病。这种疾病被称为 "睾丸癌相关的副肿瘤性脑炎",会导致男性出现严重的神经系统症状。他们逐渐失去对四肢、眼睛运动的控制,在某些情况下还会失去语言能力。这种疾病始于睾丸肿瘤,它似乎导致免疫系统攻击大脑。受影响的男性经常发现自己被误诊或未被诊断,适当的治疗被推迟。 发表于New England Journal of Medicine的一项研究中,科学家们通过使用 "可编程噬菌体显示 "技术的一个变体,它是一种改进的人类可编程显示系统,为筛选新抗原而设计的,可以确定了该疾病的一个高度特异和独特的生物标志物。研究人员对这种技术的改进版本同时筛选了所有人类蛋白质中的70多万个自身抗体目标。 利用这一强大的工具,加州大学旧金山分校的研究人员评估了一名37岁男子的脑脊液,该男子有睾丸癌病史,并有衰弱的神经系统症状,包括眩晕、肢体不协调和说话不清。增强的噬菌体技术确定了针对Kelch样蛋白11(KLHL11)的自身抗体,该蛋白存在于睾丸和部分大脑中。 副肿瘤性菱形脑炎患者血清抗KLHL 11抗体的发现及正交验证。 这些结果其他病人样本

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2022-01-26 ms4000002110537530

    有意思

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-30 ms7919221313595046

    nice

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-13 走,走走

    有意思

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-11 zhangph
  6. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 旺医

    顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1188318, encodeId=258e118831823, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab4b6483849, createdName=ms4000002110537530, createdTime=Wed Jan 26 15:55:40 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004066, encodeId=5ae21004066eb, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a>与<a href='/topic/show?id=1417e308648' target=_blank style='color:#2F92EE;'>#睾丸癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86337, encryptionId=e6488633e2c, topicName=自身免疫性疾病), TopicDto(id=73086, encryptionId=1417e308648, topicName=睾丸癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Fri Jul 30 22:12:42 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003816, encodeId=f3e310038167c, content=nice, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/ymoJqdF4Or52iaYU4icIF4FCnwnEtQiawHwKOASaZfIchD0cLUiaTrlCXSDyhibAaG70iarn5gwwy7aPeibtR5mAMu6jw/0, createdBy=29472170079, createdName=ms7919221313595046, createdTime=Fri Jul 30 10:32:39 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999091, encodeId=a5ab99909132, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d2873055, createdName=走,走走, createdTime=Tue Jul 13 13:02:44 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368413, encodeId=1d401368413f3, content=<a href='/topic/show?id=2fa7e3068b9' target=_blank style='color:#2F92EE;'>#睾丸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73068, encryptionId=2fa7e3068b9, topicName=睾丸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580175, encodeId=aa0815801e5aa, content=<a href='/topic/show?id=bd2529020e1' target=_blank style='color:#2F92EE;'>#免疫性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29020, encryptionId=bd2529020e1, topicName=免疫性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0516593209, createdName=124988c7m100暂无昵称, createdTime=Sun Jul 11 14:13:42 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998300, encodeId=9c6599830063, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jul 10 22:44:49 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035691, encodeId=a531103569115, content=顶刊就是顶刊,谢谢williamhill asia 带来这么高水平的研究报道,williamhill asia 科里同事经常看williamhill asia ,分享williamhill asia 上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Sat Jul 10 02:13:42 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998102, encodeId=99ed99810236, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Sat Jul 10 00:23:46 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 仁术2021

    不错学习了

    0

相关威廉亚洲官网

Brit J Cancer:癌症家族史与儿童和青年人睾丸癌风险

该研究发现患有TC、癌、间皮瘤、肉瘤、恶性黑素瘤和恶性神经上皮肿瘤家族史的儿童和年轻人患TC的风险增加。遗传性癌症综合征可能是本研究报道的一些关联的基础。

Sci Rep:睾丸癌患者异种移植模型的建立和表征-用于新治疗策略的临床前评估

睾丸癌(TC)是年轻男性最常见的实体瘤。虽然基于顺铂化疗对TC患者非常有效,但化疗抗性的产生仍占疾病相关死亡的10%。因此,需要能够真实反映患者肿瘤的临床前模型来协助靶点发现和药物开发。

Laryngoscope:扩展随访期间顺铂相关的和年龄相关的听力损失关系研究

顺铂相关的听力损失(HL)在治疗后产生。最近,有研究人员在控制的纵向研究的扩展随访中调查了顺铂化疗(CBCT)睾丸癌幸存者(TCSs)中的HL情况。研究包括了82名CBCT治疗的TCSs患者,时间为1980年到1994年之间,且参与了2种调查,包括12年后纯音听觉测试(0.125-8kHz)和31年后自我报道的HL。听力阈值为基于普通对照且年龄匹配群体听力阈值年龄调整后的。听力损失定义为在任何频率

NCCN临床实践威廉亚洲博彩公司 :睾丸癌(2020.V1)

2019年10月,美国国家综合癌症网络(NCCN)发布了睾丸癌威廉亚洲博彩公司 2020年第1版,威廉亚洲博彩公司 主要内容涉及: 威廉亚洲博彩公司 更新摘要 检查,初级治疗和病理诊断 单纯精原细胞癌诊断后检查和临床分期 非精原细胞癌诊断后检查和临床分期 复发和二线治疗 精原细胞癌的随访 非精原细胞瘤的随访 单纯睾丸精原细胞癌放射治疗原则 进展期疾病风险分层 生殖细胞肿瘤初始化疗方案 转移性生殖细胞瘤二线化疗方案 转移性生殖细胞瘤后续性化

NCCN临床实践威廉亚洲博彩公司 :睾丸癌(2019.V1)

2018年10月,美国国家综合癌症网络(NCCN)发布了睾丸癌威廉亚洲博彩公司 2019年第1版,威廉亚洲博彩公司 主要内容涉及: 威廉亚洲博彩公司 更新摘要 检查,初级治疗和病理诊断 单纯精原细胞癌诊断后检查和临床分期 非精原细胞癌诊断后检查和临床分期 复发和二线治疗 精原细胞癌的随访 非精原细胞瘤的随访 单纯睾丸精原细胞癌放射治疗原则 进展期疾病风险分层 生殖细胞肿瘤初始化疗方案 转移性生殖细胞瘤二线化疗方案 转移性生殖细胞瘤后续性化

Br J Cancer:顺铂治疗加速睾丸癌幸存者的血管老化

睾丸癌(TC)虽然仅占男性所有癌症的1%,却是影响15至35岁男性的最常见的实体瘤。根据疾病的分期,一般采取睾丸切除术或切除术结合放疗(RT)、铂类药物化疗(CT)的方式进行治疗。至顺铂(cispla

拓展阅读

不用手术,近3年肿瘤未生长或转移!中肿徐瑞华:联合疗法为直肠癌患者带来新选择

研究表明新辅助放化疗联合PD-1抗体信迪利单抗(sintiliumab)可增加完全缓解率且安全可控,PD-L1联合阳性评分(CPS)可作为评估协同效应的生物标志物。

王孝深教授组稿|赵阳:选择性剪切在头颈鳞癌中作用概述

本期「专家组稿」由复旦大学附属眼耳鼻喉科医院王孝深教授担任执行主编,与复旦大学附属眼耳鼻喉科医院赵阳博士分享《选择性剪切在头颈鳞癌中作用概述》,为医者和患者提供更多参考。

Clin Cosmet Investig Dermatol:南京医科大学第一附属医院发文白癜风和桥本甲状腺炎共享生物标志物和免疫浸润特征的鉴定

白癜风和桥本甲状腺炎(HT)是伴随性自身免疫性疾病,其特征是黑素细胞或甲状腺细胞的破坏。williamhill asia 的目的是探索这种合并症的免疫学机制,并筛选其潜在的生物标志物。

读书报告 | 免疫治疗标志物PD(L)1表达的评估方法

本文介绍了PD-1/PD-L1评估的现状,对如何提高预测ICIs反应的生物标志物的准确性进行了系统的综述。

Mol Cancer:孙蓬明/杨俊涛/柳江枫合作多组学揭示早期子宫内膜癌新恶性亚群及预后生物标志物

该研究对24例具有不同生存结果的早期子宫内膜样EC患者的癌组织和癌旁组织进行蛋白质组学分析后,筛选出13种差异表达蛋白,同时通过单细胞转录组进一步鉴定了2种富集于p53信号通路的蛋白。

Alzheimer’s & Dementia:脑脊液中胶质生物标志物与认知功能存在显著关联

研究发现CSF中的胶质生物标志物GFAP、YKL-40和sTREM2水平与认知功能显著相关,特别是在有认知风险的个体中,这些标志物可以作为阿尔茨海默病早期诊断和预测的重要指标。